ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 624227 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 624227; 2) Community: the network communities that were significantly associated with the response to NSC 624227; 3) Molecule: the relationships between components within communities and NSC 624227; 4) MDR: the compounds that were significantly associated with the NSC 624227.

NSC Compound Enrichment Correlation
NSC 677959 16.beta.-N-methylpiperazino-5-androstene-3.beta.,17.beta.-diol 0.0406225271888773 0.1830423
NSC 679600 Null 0.0406225271888773 0.38238404
NSC 682298 Camptothecin Derivative 0.0406225271888773 0.096844282
NSC 682831 Butanimidoyl chloride, N-[[[(3-fluorophenyl)amino] carbonyl]oxy]- 0.0406225271888773 0.24657853
NSC 683332 Spiro[2a,8a-epoxyanthra[2,3-b]oxirene- 2-(1aH),2'-naphtho[1,8-de][1,3]dioxin]-3,8(9H,9aH)-dione, 9-hydroxy-, stereoisomer 0.0406225271888773 0.34844828
NSC 683518 Null 0.0406225271888773 0.11388176
NSC 684567 4,6(1H,5H)-Pyrimidinedione, 5-[3-[4-(diethylamino)phenyl]- 2-propenylidene]-2,3-dihydro-2-thioxo- 0.0406225271888773 0.16824373
NSC 688285 7,8-Dehydrocalotropin 0.0406225271888773 0.070666938
NSC 696253 2-Propyn-1-one, 3-(2,4-dimethoxy-5-pyrimidinyl)-1-(3-methoxyphenyl)- 0.0406225271888773 0.30560382
NSC 700262 Null 0.0406225271888773 -0.071168112
Total:69  Current:56    [First] [Prev] [Next] [Last]